EP 3864034 A1 20210818 - CELL
Title (en)
CELL
Title (de)
ZELLE
Title (fr)
CELLULE
Publication
Application
Priority
- GB 201816399 A 20181008
- GB 2019052829 W 20191007
Abstract (en)
[origin: WO2020074868A1] The present invention relates to a cell which co-expresses (i) a dominant-negative SMAD (dnSMAD); and (ii).a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR).
IPC 8 full level
C07K 14/725 (2006.01); C07K 14/705 (2006.01); C12N 5/071 (2010.01)
CPC (source: EP US)
A61K 39/4611 (2023.05 - EP US); A61K 39/4631 (2023.05 - EP US); A61K 39/464471 (2023.05 - EP US); C07K 14/7051 (2013.01 - EP); C07K 14/70521 (2013.01 - EP); C12N 5/0636 (2013.01 - EP US); C12N 2501/515 (2013.01 - EP); C12N 2510/00 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020074868 A1 20200416; EP 3864034 A1 20210818; GB 201816399 D0 20181128
DOCDB simple family (application)
GB 2019052829 W 20191007; EP 19791327 A 20191007; GB 201816399 A 20181008